BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 841179)

  • 1. Anti leukemia activity (L1210) of 6-mercaptopurine and its metallo complexes in mice.
    Skinner SM; Lewis RW
    Res Commun Chem Pathol Pharmacol; 1977 Jan; 16(1):183-6. PubMed ID: 841179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti leukemia activity (Dunning ascitic) of 6-mercaptopurine and its metallo complexes in rats.
    Skinner SM; Swatzell JM; Lewis RW
    Res Commun Chem Pathol Pharmacol; 1978 Jan; 19(1):165-8. PubMed ID: 625586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metal chelates as anti-cancer agents. II cytotoxic action of palladium and platinum complexes of 6-mercaptopurine and thioguanine.
    Das M; Livingstone SE
    Br J Cancer; 1978 Aug; 38(2):325-8. PubMed ID: 698049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectral characteristics of some metallo complexes of six-mercaptopurine.
    Lewis RW; Olivier G
    Res Commun Chem Pathol Pharmacol; 1976 Jan; 13(1):137-40. PubMed ID: 1257596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pt(II) and Pd(II) complexes of 3-aminoflavone: in vitro and in vivo evaluation.
    Zyner E; Graczyk J; Ochocki J
    Pharmazie; 1999 Dec; 54(12):945-6. PubMed ID: 10631759
    [No Abstract]   [Full Text] [Related]  

  • 6. Lack of cross-resistance between certain platinum coordination compounds in mouse leukemia.
    Burchenal JH; Kalaher K; O'Toole T; Chisholm J
    Cancer Res; 1977 Sep; 37(9):3455-7. PubMed ID: 884687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro biological activity of new platinum(II) and palladium(II) complex compounds].
    Malinowska K; Modranka R; Kubiak K; Mrowicka M; Kedziora J; Klimczak A; Rutkowski M
    Pol Merkur Lekarski; 2009 Jan; 26(151):52-6. PubMed ID: 19391508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of selected six-mercaptopurine metallo-complexes on adenosine deaminase activity in rat tissues.
    Skinner SM; Lewis RW
    Res Commun Chem Pathol Pharmacol; 1983 Jan; 39(1):99-112. PubMed ID: 6682568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The return of antimetabolite sensitivity in methotrexate- and 6-mercaptopurine-resistant L1210 murine leukemia by the process of adaptive selection.
    Wallerstein H; Slater LM; Eng B; Calman N
    Cancer Res; 1972 Oct; 32(10):2235-40. PubMed ID: 5080766
    [No Abstract]   [Full Text] [Related]  

  • 10. [Testing antineoplastic activity of new platinum(II) and palladium(II) complex compounds].
    Malinowska K; Modranka R; Kubiak K; Mrowicka M; Klimczak A; Kedziora J; Rutkowski M
    Pol Merkur Lekarski; 2009 Jan; 26(151):57-61. PubMed ID: 19391509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiosensitivity of drug-resistant L1210 leukemia.
    Johnson RE
    Cancer Res; 1967 Feb; 27(2):251-4. PubMed ID: 6018559
    [No Abstract]   [Full Text] [Related]  

  • 12. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH; al-Baker S; Thai G; Khokhar AR
    Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of the antitumor effect of 6-mercaptopurine by vitamin A.
    Akiyama S; Masuda A; Tabuki T; Kuwano M; Komiyama S
    Gan; 1981 Oct; 72(5):742-6. PubMed ID: 7199007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platinum-amine compounds: importance of the labile and inert ligands for their pharmacological activities toward L1210 leukemia cells.
    Macquet JP; Butour JL
    J Natl Cancer Inst; 1983 May; 70(5):899-905. PubMed ID: 6573534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deamination of arabinosyladenine by adenosine deaminase and inhibition by arabinosyl-6-mercaptopurine.
    Chao DL; Kimball AP
    Cancer Res; 1972 Aug; 32(8):1721-4. PubMed ID: 5044132
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro oxidation of 6-MP and its metallo complexes by xanthine oxidase.
    Lewis RW; Olivier G
    Res Commun Chem Pathol Pharmacol; 1977 Oct; 18(2):377-80. PubMed ID: 918354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of antileukemic agents in advanced leukemia L1210 in mice. IX.
    Kline I; Gang M; Tyrer DD; Venditti JM; Artis EW; Goldin A
    Cancer Chemother Rep 2; 1971 Apr; 2(1):65-133. PubMed ID: 5565539
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of some sulfhydryl compounds on the antineoplastic effectiveness of 5-fluorouracil and 6-mercaptopurine.
    Danysz A; Wierzba K; Wutkiewicz M; Pniewska A; Pragłowski T; Burba-Anczewska I
    Arch Immunol Ther Exp (Warsz); 1984; 32(3):345-9. PubMed ID: 6395826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-Mercaptopurine-induced potentiation of active immunotherapy in L1210-bearing mice treated with concanavalin A-bound leukemia cell vaccine.
    Kataoka T; Akahori Y; Sakurai Y
    Cancer Res; 1984 Feb; 44(2):519-24. PubMed ID: 6537896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological and preclinical toxicological studies of 1,2-diaminocyclohexane(isocitrato)platinum(II).
    Macquet JP; Cros S; Armand JP
    Cancer Res; 1984 Sep; 44(9):3736-43. PubMed ID: 6540142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.